The fact that intratumor Regnase-1 levels were inversely associated with CD11b+ cell infiltration and clinical outcome in PDAC patients suggested tumor suppressive roles of Regnase-1 in human PDAC progression. This evidence concerns the gene ITGAM and neoplasm.